CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $530.57 ($5,040,380)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $532.24 ($5,056,298)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $531.69 ($5,051,035)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $537.05 ($5,101,939)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $530.91 ($5,043,689)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $530.35 ($5,038,340)
- 4 Planned sale EVP & GENERAL COUNSEL sold 8,300 shares at an average $533.69 ($4,429,638)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $526.83 ($5,004,909)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $535.99 ($5,091,949)
- 4 Exercise or conversion Director acquired 1,310 shares (option exercise)
- 4 Exercise or conversion Director acquired 650 shares (option exercise)
- 4 Exercise or conversion Director acquired 650 shares (option exercise)
Page 6 of 164 · 3,269 filings